These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Cyclosporin A in the treatment of Eaton-Lambert myasthenic syndrome]. Yuste Ara JR; Beloqui Ruiz O; Artieda Gonzalez-Granda J; Herrero Santos JI; De la Peña Fernandez A; Prieto Valtueña J An Med Interna; 1996 Jan; 13(1):25-6. PubMed ID: 8679819 [TBL] [Abstract][Full Text] [Related]
3. Lambert-Eaton myasthenic syndrome: evaluation of movement performance following drug therapy. Cooke JD; Hefter H; Brown SH; Toyka KV; Freund HJ Electromyogr Clin Neurophysiol; 1994 Mar; 34(2):87-93. PubMed ID: 8187683 [No Abstract] [Full Text] [Related]
4. Synaptotagmin can cause an immune-mediated model of Lambert-Eaton myasthenic syndrome in rats. Takamori M; Hamada T; Komai K; Takahashi M; Yoshida A Ann Neurol; 1994 Jan; 35(1):74-80. PubMed ID: 8285596 [TBL] [Abstract][Full Text] [Related]
5. The association of systemic lupus erythematosus and Lambert-Eaton myasthenic syndrome. Deodhar A; Norden J; So Y; Bennett R J Rheumatol; 1996 Jul; 23(7):1292-4. PubMed ID: 8823710 [TBL] [Abstract][Full Text] [Related]
6. The electrodiagnosis of myasthenia gravis and the Lambert-Eaton myasthenic syndrome. Howard JF; Sanders DB; Massey JM Neurol Clin; 1994 May; 12(2):305-30. PubMed ID: 8041344 [TBL] [Abstract][Full Text] [Related]
7. Decrement pattern in Lambert-Eaton myasthenic syndrome is different from myasthenia gravis. Baslo MB; Deymeer F; Serdaroglu P; Parman Y; Ozdemir C; Cuttini M Neuromuscul Disord; 2006 Jul; 16(7):454-8. PubMed ID: 16806929 [TBL] [Abstract][Full Text] [Related]
10. [An autoimmune disease: Lambert-Eaton syndrome. Apropos of a case]. Pinéde L; Vila A; Manquat G; Micoud M Ann Med Interne (Paris); 1996; 147(3):222-5. PubMed ID: 8796099 [No Abstract] [Full Text] [Related]
11. Lambert-Eaton myasthenic syndrome in childhood. Kostera-Pruszczyk A; Ryniewicz B; Rowinska-Marcinska K; Dutkiewicz M; Kamińska A Eur J Paediatr Neurol; 2009 Mar; 13(2):194-6. PubMed ID: 18585938 [TBL] [Abstract][Full Text] [Related]
12. Pathophysiology of myasthenia gravis and Lambert-Eaton syndrome. Maselli RA Neurol Clin; 1994 May; 12(2):285-303. PubMed ID: 8041343 [TBL] [Abstract][Full Text] [Related]
13. Atropine modulates presynaptic function in mice with passively transferred Lambert-Eaton myasthenic syndrome. Takamori M; Sakajiri K; Hamada T Muscle Nerve; 1993 Jan; 16(1):115-6. PubMed ID: 8423826 [No Abstract] [Full Text] [Related]
14. A diagnostic and management dilemma: combined paraneoplastic myasthenia gravis and Lambert-Eaton myasthenic syndrome presenting as acute respiratory failure. Roohi F; Smith PR; Bergman M; Baig MA; Sclar G Neurologist; 2006 Nov; 12(6):322-6. PubMed ID: 17122730 [TBL] [Abstract][Full Text] [Related]
15. Use of intravenous immunoglobulin in Lambert-Eaton myasthenic syndrome. Peterlin BL; Flood W; Kothari MJ J Am Osteopath Assoc; 2002 Dec; 102(12):682-4. PubMed ID: 12501987 [TBL] [Abstract][Full Text] [Related]
16. Cloning and characterization of a Lambert-Eaton myasthenic syndrome antigen. Rosenfeld MR; Wong E; Dalmau J; Manley G; Posner JB; Sher E; Furneaux HM Ann Neurol; 1993 Jan; 33(1):113-20. PubMed ID: 8494331 [TBL] [Abstract][Full Text] [Related]
17. Increased amplitude of F-response in Lambert-Eaton myasthenic syndrome. Henriet M; Jacquy J J Neurol Neurosurg Psychiatry; 1990 Feb; 53(2):174. PubMed ID: 2313309 [No Abstract] [Full Text] [Related]
18. [Lambert-Eaton myasthenic syndrome and myasthenia gravis]. Takamori M; Iwasa K; Komai K; Yasukawa Y No To Shinkei; 1997 Dec; 49(12):1089-100. PubMed ID: 9453039 [No Abstract] [Full Text] [Related]